HUP0301925A3 - A combination kit used in the treatment of malaria containing quinoline derivatives - Google Patents

A combination kit used in the treatment of malaria containing quinoline derivatives

Info

Publication number
HUP0301925A3
HUP0301925A3 HU0301925A HUP0301925A HUP0301925A3 HU P0301925 A3 HUP0301925 A3 HU P0301925A3 HU 0301925 A HU0301925 A HU 0301925A HU P0301925 A HUP0301925 A HU P0301925A HU P0301925 A3 HUP0301925 A3 HU P0301925A3
Authority
HU
Hungary
Prior art keywords
treatment
quinoline derivatives
kit used
combination kit
containing quinoline
Prior art date
Application number
HU0301925A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Nicholas Piramal India Ltd
Counsil Of Scient And Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Piramal India Ltd, Counsil Of Scient And Ind Res filed Critical Nicholas Piramal India Ltd
Publication of HUP0301925A2 publication Critical patent/HUP0301925A2/hu
Publication of HUP0301925A3 publication Critical patent/HUP0301925A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
HU0301925A 2000-05-31 2000-08-30 A combination kit used in the treatment of malaria containing quinoline derivatives HUP0301925A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN501MU2000 2000-05-31
PCT/IN2000/000081 WO2001091535A2 (en) 2000-05-31 2000-08-30 A combination kit used in the treatment of malaria containing chloroquine and 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone enthält

Publications (2)

Publication Number Publication Date
HUP0301925A2 HUP0301925A2 (hu) 2003-09-29
HUP0301925A3 true HUP0301925A3 (en) 2009-03-30

Family

ID=11097250

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301925A HUP0301925A3 (en) 2000-05-31 2000-08-30 A combination kit used in the treatment of malaria containing quinoline derivatives

Country Status (28)

Country Link
US (1) US7404962B1 (https=)
EP (1) EP1292306B1 (https=)
JP (1) JP2004505017A (https=)
KR (1) KR20030025926A (https=)
AP (1) AP1435A (https=)
AR (1) AR028458A1 (https=)
AT (1) ATE314848T1 (https=)
AU (2) AU2879001A (https=)
BR (1) BR0005247A (https=)
CA (1) CA2413775C (https=)
CR (1) CR6835A (https=)
CZ (1) CZ296875B6 (https=)
DE (2) DE60025403T2 (https=)
DK (1) DK1292306T3 (https=)
EC (1) ECSP003694A (https=)
ES (1) ES2200729T3 (https=)
GT (1) GT200000187A (https=)
HK (1) HK1052467B (https=)
HN (1) HN2001000118A (https=)
HU (1) HUP0301925A3 (https=)
MX (1) MXPA02011883A (https=)
NO (1) NO324774B1 (https=)
OA (1) OA12276A (https=)
PE (1) PE20011319A1 (https=)
PL (1) PL200748B1 (https=)
SV (1) SV2002000201A (https=)
WO (1) WO2001091535A2 (https=)
ZA (1) ZA200209726B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008135762A (ru) * 2006-02-16 2010-03-27 Де МакЛин Хоспитал Корпорейшн (US) Способы и композиции для лечения болезни паркинсона
US8658648B2 (en) 2008-12-05 2014-02-25 Designmedix, Inc. Modified chloroquines with single ring moiety or fused ring moiety
WO2010144102A1 (en) * 2009-06-09 2010-12-16 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Material Command Pentafluorosulfanyl analogs of mefloquine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US5219865A (en) * 1987-05-08 1993-06-15 Hoechst Aktiengesellschaft Pharmaceutical combination for the prophylaxis and therapy of malaria
US5373005A (en) * 1988-04-20 1994-12-13 Merrell Dow Pharmaceuticals Inc. Despiramine in the treatment of drug-resistant malarial infections
US5270037A (en) * 1990-07-12 1993-12-14 Boehringer Ingelheim Gmbh Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections
WO1993015727A1 (en) * 1992-02-07 1993-08-19 Ciba-Geigy Ag Antimalarial synergistic compositions containing benflumetol

Also Published As

Publication number Publication date
DE60025403T2 (de) 2006-08-24
ES2200729T3 (es) 2006-07-16
PE20011319A1 (es) 2002-03-02
AU2001228790B2 (en) 2007-02-01
DE60025403D1 (de) 2006-03-30
MXPA02011883A (es) 2004-05-17
HUP0301925A2 (hu) 2003-09-29
NO324774B1 (no) 2007-12-10
NO20025765L (no) 2003-01-08
CA2413775C (en) 2009-08-25
SV2002000201A (es) 2002-10-24
ECSP003694A (es) 2002-01-25
ES2200729T1 (es) 2004-03-16
CR6835A (es) 2007-04-26
GT200000187A (es) 2002-04-18
BR0005247A (pt) 2002-02-13
AR028458A1 (es) 2003-05-07
ZA200209726B (en) 2004-03-10
AU2879001A (en) 2001-12-11
DE00993875T1 (de) 2004-04-15
CA2413775A1 (en) 2001-12-06
CZ296875B6 (cs) 2006-07-12
JP2004505017A (ja) 2004-02-19
AP2002002672A0 (en) 2002-12-31
OA12276A (en) 2006-05-10
PL372718A1 (en) 2005-07-25
CZ20024071A3 (cs) 2003-04-16
DK1292306T3 (da) 2006-05-22
WO2001091535A2 (en) 2001-12-06
AP1435A (en) 2005-06-21
EP1292306B1 (en) 2006-01-04
PL200748B1 (pl) 2009-02-27
ATE314848T1 (de) 2006-02-15
HN2001000118A (es) 2001-10-29
WO2001091535B1 (en) 2002-10-31
WO2001091535A3 (en) 2002-07-04
US7404962B1 (en) 2008-07-29
HK1052467A1 (en) 2003-09-19
KR20030025926A (ko) 2003-03-29
HK1052467B (en) 2006-03-10
NO20025765D0 (no) 2002-11-29
EP1292306A2 (en) 2003-03-19

Similar Documents

Publication Publication Date Title
PL357210A1 (en) Novel use
EP1306101A4 (en) PROTECTED NEEDLE
EP1313477A4 (en) COMPILATIONS AND METHODS
EP1274424A4 (en) CONNECTIONS AND PROCEDURE
GB0021303D0 (en) Use
AU2001269291A1 (en) Therapeutic acridone and acridine compounds
GB0025788D0 (en) Use
GB2351916B (en) Putters
HUP0301925A3 (en) A combination kit used in the treatment of malaria containing quinoline derivatives
GB0021497D0 (en) Compounds and their use
GB0007530D0 (en) Trityl-type compounds and their use
GB0027783D0 (en) Novel use
GB0006864D0 (en) New use
GB0006129D0 (en) Pool table
GB0029634D0 (en) Use
GB0004183D0 (en) New use
GB0019790D0 (en) Putter
GB2357692B (en) Preparation and combination tool
GB9919986D0 (en) The handy piece of kit
PL342977A1 (en) Orthographic dominoes
AU7035601A (en) Novel compounds and methods
AU141346S (en) Set of trophies
GB0011799D0 (en) Use
GB0002113D0 (en) Use
GB0014192D0 (en) Use